Superficially, business looks like a dream from growth >20% and RoE >35% percentages, and P/E ratio is ~13 net of cash. We already know that this investigation itself has not had much impact (especially after more products were removed), and that although further growth might be slowed down, the real question is whether the company is worth even 620 a share knowing that further growth might slow. From the looks of it, a 13x P/E ratio shows all further growth discounted, so i’m considering investing.
Disc: I currently hold long exposure to DivisLab by selling Put contracts
Also, I think members on this forum should consider using their directional views on a stock like divis to try option contracts. For example, if you perceive divis to have gotten past its FDA issues and expect it to slowly drift up, it would be a good idea to sell puts (and maybe even OTM Calls) on Divis for maximum profit. I think option strategies can be great when paired with fundamental analysis